Paeds SAQs · cardiology
Long-QT syndrome and channelopathies — formative SAQs
Formative SAQs on long-QT syndrome and channelopathies: the genotype-specific triggers, the Schwartz diagnostic score and manual QTc measurement, the beta-blocker-first management with LCSD and ICD escalation, and the related entity CPVT with its structurally normal heart and normal resting ECG.
On this page & tools
Target exams
SAQ 1 (10 marks)
A nine-year-old girl is brought to the emergency department after collapsing during a school swimming carnival. She was pulled from the pool unconscious, had brief jerking movements of her limbs, and recovered fully within two minutes. Her mother, who has had "fainting spells" all her life, wonders if this was a seizure. The triage label reads "vasovagal or seizure — query epilepsy." The registrar has ordered a CT head and an EEG. Her twelve-lead ECG shows a QTc of 520 milliseconds. [1] [2]
- Give the immediate diagnostic and initial management steps for this child, explaining the significance of the QTc and the errors the triage team is making. (4) [1] [3]
- Describe the investigation strategy that confirms the diagnosis and identifies the genotype, and explain why the genotype matters for management. (3) [1] [3]
- Outline the definitive management, including the first-line therapy, its expected efficacy, and the circumstances that would prompt escalation. (3) [4] [5]
Model answer — SAQ 1
(1) Immediate diagnostic and management steps (4). This is a high-probability presentation of long-QT syndrome: syncope during exertion (swimming), seizure-like movements during cerebral hypoxia from a transient arrhythmia, a maternal history of "fainting," and a QTc of 520 milliseconds which is diagnostic of LQTS regardless of symptoms. The team's errors are triaging this as a neurological event (CT, EEG) rather than a cardiac one, and not recognising that exercise-related syncope with a prolonged QTc is arrhythmic until proven otherwise. The immediate steps are to admit the child for cardiac monitoring, stop any QT-prolonging medications, maintain electrolytes (particularly potassium above 4.0 mmol/L), and refer urgently to the inherited cardiac conditions service. The child must not return to swimming or competitive sport until assessed. The maternal history of fainting warrants investigation for familial LQTS with cascade screening. [1] [3]
(2) Investigation strategy and genotype (3). The diagnosis is confirmed by the Schwartz diagnostic score, which integrates the QTc (520 ms scores 3 points), the syncopal event triggered by exertion (2 points), and the family history (at least 0.5 points), giving a score well above the high-probability threshold of four. Genetic testing for the three major genes (KCNQ1, KCNH2, SCN5A) should be requested through the inherited cardiac conditions service; the yield is approximately seventy to seventy-five per cent for these three genes. The genotype matters because it determines the trigger profile, the response to beta-blockers, and the threshold for aggressive therapy: LQT1 (KCNQ1, the likely genotype given the swimming trigger) is well-protected by beta-blockers, LQT2 has intermediate response, and LQT3 responds poorly and may need mexiletine or an ICD at a lower threshold. Echocardiography excludes structural heart disease, and an exercise test may be useful to assess QT adaptation if the resting QTc is borderline. [1] [3]
(3) Definitive management (3). The first-line therapy is a beta-blocker — nadolol (0.5–2 mg/kg/day) is the preferred agent in children because of its long half-life and tolerability. Beta-blockers reduce arrhythmic events by approximately two-thirds across the LQTS cohort, though efficacy is genotype-dependent (best in LQT1, worst in LQT3). Lifestyle modification is universal: restriction from competitive and exertional sports, avoidance of QT-prolonging medications for life, and aggressive correction of electrolyte disturbance during intercurrent illness. Escalation to left cardiac sympathetic denervation (LCSD) is warranted for breakthrough events on maximally tolerated beta-blockers — LCSD reduces events by over ninety per cent and is the preferred intermediate step in children before an implantable cardioverter defibrillator. An ICD is reserved for the highest-risk patients: survivors of aborted cardiac arrest, those with recurrent syncope despite beta-blockers and LCSD, or very high-risk genotypes such as LQT3 with QTc above 500 milliseconds. [4] [5]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References6Show ledgerHide ledger
- [1]Schwartz PJ, Moss AJ, Vincent GM, Crampton RS Diagnostic criteria for the long QT syndrome. An update. Circulation, 1993.PMID 8339437
- [2]Abrams DJ, Macrae CA Long QT syndrome. Circulation, 2014.PMID 24709866
- [3]Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm, 2013.PMID 24011539
- [4]Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation, 2000.PMID 10673253
- [5]Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation, 2004.PMID 15051644
- [6]Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace, 2015.PMID 26318695